ReviewRomanian journal of ophthalmology
The Evolution of Vision Therapy Software and Its Impact on Vision Care - A Comprehensive Major Review.
Review in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The integration of vision therapy software (VTS) has brought about a paradigm shift in the treatment of various visual disorders, enhancing patient engagement, therapy effectiveness, and accessibility. The advent of VTS has revolutionized the management of binocular vision disorders, amblyopia, convergence insufficiency, and post-traumatic visual dysfunctions, providing a technologically advanced, accessible, and engaging alternative to traditional in-office therapy. VTS leverages artificial intelligence (AI), virtual reality (VR), augmented reality (AR), and wearable technologies to create interactive, adaptive, and personalized training environments that enhance neuroplasticity and visual rehabilitation. This review explores the evolution, mechanisms, and clinical applications of VTS, emphasizing its role in improving visual acuity, binocular coordination, vergence, and accommodative functions. Evidence from meta-analyses, clinical trials, and case studies supports its effectiveness, with notable benefits in patient adherence, treatment flexibility, and cost reduction. Additionally, telemedicine integration and remote monitoring have expanded access to vision therapy, particularly in underserved and remote populations. Despite its advantages, challenges remain, including the need for professional supervision, variability in patient response, lack of standardization, and data privacy concerns. Furthermore, long-term comparative studies are necessary to validate its efficacy against traditional vision therapy methods. Emerging AI-driven personalization, immersive VR/AR environments, and real-time biofeedback mechanisms are expected to enhance VTS, making it a crucial component of modern vision rehabilitation. As digital therapeutics continue to evolve, a hybrid model combining VTS with clinician-guided therapy appears to be the most effective approach. This paradigm shift underscores VTS's future potential to redefine vision care and bridge the gap between clinical expertise and innovative digital health solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.